Bridging the Gap: Integrating the Latest Approved Therapies for BCG-unresponsive NMIBC - CME - Guideline Central

CME

Title
Bridging the Gap: Integrating the Latest Approved Therapies for BCG-unresponsive NMIBC
Link
Description
Non-muscle-invasive bladder cancer (NMIBC) brings about symptoms of pain, fatigue, and sexual dysfunction. These symptoms disrupt daily life and impact well-being and point to a need for improved treatment strategies. Bacillus Calmette-Guérin (BCG) therapy following transurethral resection of bladder tumor (TURBT) has long been the standard of care for high-risk (HR) NMIBC; however, more than half of patients relapse or progress within 1 to 2 years, and 30% to 40% develop BCG-unresponsive disease (BCG-UR).
Target Audience
The educational design of this activity addresses the needs of oncologists, urologists, and advanced practice providers, nurses.
Learning Objectives
  • Outline the mechanisms of action of novel therapies for BCG-unresponsive NMIBC
  • Review efficacy and safety data for novel therapies in BCG-unresponsive NMIBC
  • Compare novel treatment options for BCG-unresponsive NMIBC by incorporating patient-specific factors to support clinical decision-making
Estimated Duration
45 minutes
Delivery Mode
Online
Format
Online Learning
Specialties
Urology
Disclosures and Disclaimers
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Accredited Providers
  • Global Education Group
  • MedliveCME
  • Large Urology Group Practice Association (LUGPA)
Commercial Support
  • Ferring Pharmaceuticals Inc
Activity Expiration Date
March 18, 2027
Credit Information
Credit TypeUnits / Unit TypeBoard
AMA PRA Category 1 Credit0.75 CreditsACCME- Accreditation Council for Continuing Medical Education
You rely on Guideline Central for transparency

Guideline Central and select third party use “cookies” on this website to enhance the user experience.

This technology helps us gather statistical and analytical information to optimize the relevant content for you.

The user also has the option to opt-out which may have an effect on the browsing experience.